ADC Therapeutics SA (ADCT) said Jay Feingold, Senior Vice President and Chief
Medical Officer, will depart the company. Joseph Camardo will be appointed Senior Vice
President and Chief Medical Officer. Camardo joined the company from Celgene Corporation, where he was most recently Senior Vice President of Celgene Global Health.
"Camardo worked closely with Feingold for the last 18 months and together they ensured our first marketed product was well-received by the physician community in the United States and beyond," said Chris Martin, CEO.
Based in Lausanne (Biople), Switzerland, ADC Therapeutics has operations in London, the San Francisco Bay Area and New Jersey.
For comments and feedback: editorial@rttnews.com